HAL vs VTAK · P/E 9.3, $19.05B cap vs rev $420.0K
Halliburton Company (HAL) versus Catheter Precision Inc. (VTAK) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Catheter Precision Inc. (VTAK) is a medical devices company listed on US.
HAL does not have a complete income-statement cache yet.
Latest reported VTAK revenue for 2024-12-31 was $420.0K. Net income was -$16.6M. Revenue was down 5.0% from 2023-12-31 to 2024-12-31. VTAK currently screens at market cap $3.0M.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. VTAK currently screens at market cap $3.0M.
Not investment advice. Open the HAL and VTAK stock pages for the full models.
Not investment advice.